Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novocure Ltd Ord Sh
(NQ:
NVCR
)
75.35
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 7, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1
Open
75.35
Bid (Size)
69.80 (1)
Ask (Size)
76.01 (1)
Prev. Close
75.35
Today's Range
75.35 - 75.35
52wk Range
56.39 - 94.00
Shares Outstanding
103,647,871
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
5 Top Stocks for December
December 04, 2022
From game-changing products to indisputable growth catalysts, this list of top stocks has something for all.
Via
The Motley Fool
12 Top Stocks to Buy in December
December 03, 2022
Add this dandy dozen to your stocking this month.
Via
The Motley Fool
Performance
YTD
-5.93%
-5.93%
1 Month
+4.23%
+4.23%
3 Month
-9.09%
-9.09%
6 Month
-2.46%
-2.46%
1 Year
-16.22%
-16.22%
More News
Read More
Where NovoCure Stands With Analysts
November 29, 2022
Via
Benzinga
Why Novocure Stock Is Jumping Today
November 29, 2022
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
November 29, 2022
Via
Benzinga
5 Analysts Have This to Say About NovoCure
November 29, 2022
Via
Benzinga
Novocure Stock: Bull vs. Bear
November 26, 2022
Via
The Motley Fool
Novocure’s Optune® Approved in Canada for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
November 29, 2022
From
Novocure
Via
Business Wire
FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday
November 29, 2022
Via
Benzinga
3 Growth Stocks to Buy That Could Skyrocket
November 28, 2022
Via
The Motley Fool
Novocure to Participate in 34th Annual Piper Sandler Healthcare Conference
November 23, 2022
From
Novocure
Via
Business Wire
What 4 Analyst Ratings Have To Say About NovoCure
October 28, 2022
Via
Benzinga
Where NovoCure Stands With Analysts
October 28, 2022
Via
Benzinga
Novocure Announces 25 Abstracts on Tumor Treating Fields Therapy at Society for Neuro-Oncology 2022 Annual Meeting
November 17, 2022
From
Novocure
Via
Business Wire
Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada
November 15, 2022
From
Novocure
Via
Business Wire
Novocure Secures CE Mark for New Array
November 11, 2022
From
Novocure
Via
Business Wire
Novocure (NVCR) Q3 2022 Earnings Call Transcript
October 27, 2022
Via
The Motley Fool
Why Novocure Stock Is Sinking Today
October 24, 2022
Via
The Motley Fool
2 Potentially Explosive Stocks to Buy in November
November 08, 2022
Via
The Motley Fool
NovoCure's Return On Capital Employed Insights
November 02, 2022
Via
Benzinga
3 Unstoppable Stocks That Could Double in 5 Years
October 29, 2022
Via
The Motley Fool
NovoCure: Q3 Earnings Insights
October 27, 2022
Via
Benzinga
Novocure Reports Third Quarter 2022 Financial Results
October 27, 2022
From
Novocure
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022
October 24, 2022
Via
Benzinga
CSX To Rally 20%? Here Are 5 Other Price Target Changes For Monday
October 24, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
